Infarct Avid Scintigraphy

Infarct Avid Scintigraphy is a diagnostic test used in cardiology to detect and localize ischemic heart disease, also known as coronary artery disease. This condition occurs when there is a narrowing or blockage in the blood vessels that supply the heart muscles with oxygen and nutrients, leading to reduced blood flow and damage to the heart. Infarct Avid Scintigraphy is a non-invasive imaging technique that uses a radiopharmaceutical agent, such as Technetium-99m-tetrofosmin or Technetium-99m-sestamibi, to detect the areas of the heart that are not receiving adequate blood flow. The agent is injected into the patient's bloodstream, and then a special camera, known as a gamma camera, is used to capture images of the heart. The radiopharmaceutical agent that is used in Infarct Avid Scintigraphy is taken up by the heart cells in proportion to their metabolic activity. Cells that are not receiving enough blood, such as those affected by ischemia, take up less of the agent and appear as "cold spots" on the images. In contrast, cells that are healthy and well-perfused with blood take up more of the agent and appear as "hot spots" on the images. Infarct Avid Scintigraphy can be used to identify the location and extent of an ischemic event in the heart, as well as to monitor the progression of the disease over time. It can also be used to evaluate the effectiveness of treatments, such as medication or revascularization procedures, by comparing pre- and post-treatment images. In conclusion, Infarct Avid Scintigraphy is an important tool in the diagnosis and management of ischemic heart disease, allowing physicians to identify and localize areas of reduced blood flow to the heart. It is a safe and non-invasive procedure that can provide valuable information to guide treatment and improve outcomes for patients with this condition.